These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 36711204)
41. (123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study. Tiraboschi P; Corso A; Guerra UP; Nobili F; Piccardo A; Calcagni ML; Volterrani D; Cecchin D; Tettamanti M; Antelmi L; Vidale S; Sacco L; Merello M; Stefanini S; Micheli A; Vai P; Capitanio S; Gabanelli SV; Riva R; Pinto P; Biffi AM; Muscio C; Ann Neurol; 2016 Sep; 80(3):368-78. PubMed ID: 27398636 [TBL] [Abstract][Full Text] [Related]
42. 123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders. Nuvoli S; Spanu A; Piras MR; Nieddu A; Mulas A; Rocchitta G; Galleri G; Serra PA; Madeddu G Medicine (Baltimore); 2017 May; 96(21):e6967. PubMed ID: 28538394 [TBL] [Abstract][Full Text] [Related]
43. Diagnostic cutoff points for ¹²³I-MIBG myocardial scintigraphy in a Caucasian population with Parkinson's disease. Muxí A; Paredes P; Navales I; Valldeoriola F; Gaig C; Lomeña F; de la Cerda A; Solà O; Domenech B; Tolosa E; Pons F Eur J Nucl Med Mol Imaging; 2011 Jun; 38(6):1139-46. PubMed ID: 21373765 [TBL] [Abstract][Full Text] [Related]
44. Transcranial sonography of the substantia nigra and MIBG myocardial scintigraphy: complementary role in the diagnosis of Parkinson's disease. Kajimoto Y; Miwa H; Okawa-Izawa M; Hironishi M; Kondo T Parkinsonism Relat Disord; 2009 May; 15(4):270-2. PubMed ID: 18691928 [TBL] [Abstract][Full Text] [Related]
45. Diagnostic value of 18F-FDG PET/CT in paediatric neuroblastoma: comparison with 131I-MIBG scintigraphy. Dhull VS; Sharma P; Patel C; Kundu P; Agarwala S; Bakhshi S; Bhatnagar V; Bal C; Kumar R Nucl Med Commun; 2015 Oct; 36(10):1007-13. PubMed ID: 26049371 [TBL] [Abstract][Full Text] [Related]
46. Diagnostic value of FDG PET and salivary gland scintigraphy for parotid tumors. Uchida Y; Minoshima S; Kawata T; Motoori K; Nakano K; Kazama T; Uno T; Okamoto Y; Ito H Clin Nucl Med; 2005 Mar; 30(3):170-6. PubMed ID: 15722820 [TBL] [Abstract][Full Text] [Related]
47. Validation of Iodine-131-meta-iodobenzylguanidine cardiac scintigraphy in Parkinsonism: A preliminary study. Xu D; Zhu W; Huo L; Zhu S; Li F; Wang H Parkinsonism Relat Disord; 2018 May; 50():69-73. PubMed ID: 29475590 [TBL] [Abstract][Full Text] [Related]
48. Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease. Courbon F; Brefel-Courbon C; Thalamas C; Alibelli MJ; Berry I; Montastruc JL; Rascol O; Senard JM Mov Disord; 2003 Aug; 18(8):890-7. PubMed ID: 12889078 [TBL] [Abstract][Full Text] [Related]
49. Myocardial MIBG scintigraphy in genetic Parkinson's disease as a model for Lewy body disorders. Gabilondo I; Llorens V; Rodriguez T; Fernández M; Concha TP; Acera M; Tijero B; Murueta-Goyena A; Del Pino R; Cortés J; Gómez-Esteban JC Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):376-384. PubMed ID: 30324423 [TBL] [Abstract][Full Text] [Related]
50. Diagnostic accuracy of combined FP-CIT, IBZM, and MIBG scintigraphy in the differential diagnosis of degenerative parkinsonism: a multidimensional statistical approach. Südmeyer M; Antke C; Zizek T; Beu M; Nikolaus S; Wojtecki L; Schnitzler A; Müller HW J Nucl Med; 2011 May; 52(5):733-40. PubMed ID: 21498527 [TBL] [Abstract][Full Text] [Related]
51. MIBG Myocardial Scintigraphy Identifies Premotor PD/DLB During a Negative DAT Scan Period: Second Report. Sakakibara R; Tateno F; Aiba Y; Ogata T; Kishi M; Terada H; Inaoka T; Nakatsuka T; Matsuoka K Mov Disord Clin Pract; 2019 Jan; 6(1):46-50. PubMed ID: 30746415 [TBL] [Abstract][Full Text] [Related]
52. Differential diagnosis of parkinsonism: a head-to-head comparison of FDG PET and MIBG scintigraphy. Brumberg J; Schröter N; Blazhenets G; Frings L; Volkmann J; Lapa C; Jost WH; Isaias IU; Meyer PT NPJ Parkinsons Dis; 2020 Dec; 6(1):39. PubMed ID: 33311476 [TBL] [Abstract][Full Text] [Related]
53. Cardiac 123I-MIBG Scintigraphy in Neurodegenerative Parkinson Syndromes: Performance and Pitfalls in Clinical Practice. Skowronek C; Zange L; Lipp A Front Neurol; 2019; 10():152. PubMed ID: 30863360 [No Abstract] [Full Text] [Related]
54. The potential role of the cardiac MIBG scan in differentiating the drug-induced Parkinsonism from Parkinson's disease. Shafie M; Mayeli M; Saeidi S; Mirsepassi Z; Abbasi M; Shafeghat M; Aghamollaii V Clin Park Relat Disord; 2022; 6():100130. PubMed ID: 35146407 [TBL] [Abstract][Full Text] [Related]
56. The role of 123I-metaiodobenzylguanidine myocardial scintigraphy in the diagnosis of Lewy body disease in patients with dementia in a memory clinic. Hanyu H; Shimizu S; Hirao K; Sakurai H; Iwamoto T; Chikamori T; Hida S; Yamashina A; Koizumi K; Abe K Dement Geriatr Cogn Disord; 2006; 22(5-6):379-84. PubMed ID: 16960446 [TBL] [Abstract][Full Text] [Related]
58. FP-CIT and MIBG scintigraphy in early Parkinson's disease. Spiegel J; Möllers MO; Jost WH; Fuss G; Samnick S; Dillmann U; Becker G; Kirsch CM Mov Disord; 2005 May; 20(5):552-61. PubMed ID: 15645531 [TBL] [Abstract][Full Text] [Related]
59. The diagnostic value of minor salivary gland biopsy in clinically diagnosed patients with Parkinson's disease: comparison with DAT PET scans. Gao L; Chen H; Li X; Li F; Ou-Yang Q; Feng T Neurol Sci; 2015 Sep; 36(9):1575-80. PubMed ID: 25820147 [TBL] [Abstract][Full Text] [Related]